Petar Alaupovic
#123,439
Most Influential Person Now
Petar Alaupovic's AcademicInfluence.com Rankings
Petar Alaupovicmedical Degrees
Medical
#1924
World Rank
#2310
Historical Rank
Cardiology
#157
World Rank
#162
Historical Rank
Public Health
#265
World Rank
#274
Historical Rank
Epidemiology
#312
World Rank
#329
Historical Rank
Petar Alaupovicphilosophy Degrees
Philosophy
#5667
World Rank
#8535
Historical Rank
Logic
#2908
World Rank
#3980
Historical Rank
Download Badge
Medical Philosophy
Petar Alaupovic's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
- Masters Public Health University of California, Berkeley
Similar Degrees You Can Earn
Why Is Petar Alaupovic Influential?
(Suggest an Edit or Addition)Petar Alaupovic's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS) (1993) (645)
- VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial (2000) (478)
- Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. (1985) (427)
- Beneficial Effects of Colestipol‐Niacin Therapy on the Common Carotid Artery. Two‐ and Four‐Year Reduction of Intima‐Media Thickness Measured by Ultrasound (1993) (388)
- Lipoprotein metabolism and renal failure. (1993) (373)
- Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) (2003) (366)
- Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy (1996) (344)
- Triglyceride‐ and Cholesterol‐Rich Lipoproteins Have a Differential Effect on Mild/Moderate and Severe Lesion Progression as Assessed by Quantitative Coronary Angiography in a Controlled Trial of Lovastatin (1994) (339)
- A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. (1969) (335)
- Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. (1982) (319)
- Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. (1990) (314)
- Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. (1976) (297)
- Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. (1972) (288)
- Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. (1997) (235)
- The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. (2002) (226)
- Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. (1981) (196)
- Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. (1978) (195)
- Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. (1991) (188)
- The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. (1997) (183)
- A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. (1970) (165)
- STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM. (1965) (164)
- Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. (1972) (163)
- Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. (1983) (162)
- Determination of human apolipoprotein E by electroimmunoassay. (1976) (159)
- Quantitative determination of human apolipoprotein C-III by electroimmunoassay. (1980) (158)
- Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. (1976) (148)
- Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system (1973) (148)
- Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study. (2008) (136)
- Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. (1989) (130)
- Apoliproproteins and lipoproteins. (1971) (127)
- Lipid abnormalities in chronic renal insufficiency. (1991) (123)
- Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. (1998) (116)
- Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. (1987) (113)
- Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins123 (2011) (113)
- Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. (1966) (112)
- Serum apolipoprotein profile of patients with chronic renal failure. (1987) (105)
- Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families. (1991) (105)
- Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion (1981) (100)
- Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. (1996) (98)
- Conceptual Development of the Classification Systems of Plasma Lipoproteins (1972) (98)
- Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. (1983) (97)
- Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. (1996) (96)
- High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis: A Randomized Controlled Trial (2009) (94)
- Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. (1978) (91)
- Studies of the composition and structure of plasma lipoproteins. C‐ and N‐terminal amino acids of the two nonidentical polypeptides of human plasma apolipoprotein A (1971) (89)
- Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. (1990) (88)
- Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. (1993) (86)
- Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. (1999) (86)
- Dialysis modalities and dyslipidemia. (2003) (86)
- Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. (1984) (85)
- Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. (1981) (77)
- Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. (2002) (75)
- Lipid and apolipoprotein abnormalities in hirsute women: I. The association with insulin resistance (1992) (73)
- The concept of apolipoprotein-defined lipoprotein families and its clinical significance (2003) (72)
- David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. (1981) (71)
- STUDIES OF THE METABOLISM OF RADIOIODINATED HUMAN SERUM ALPHA LIPOPROTEIN IN NORMAL AND HYPERLIPIDEMIC SUBJECTS. (1964) (68)
- Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. (1988) (68)
- Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. (1996) (65)
- Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. (1977) (65)
- Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. (1979) (63)
- Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. (1984) (63)
- The compositional abnormalities of lipoproteins in diabetic renal failure. (1998) (61)
- Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. (1999) (60)
- Studies on the characterization of human erythrocyte acetylcholinesterase and its interaction with antibodies. (1977) (58)
- Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia. (1991) (57)
- Differential activation of lipoprotein lipase from human post‐heparin plasma, milk and adipose tissue by polypeptides of human serum Apolipoprotein C (1971) (57)
- Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease. (1996) (56)
- Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. (1987) (55)
- Studies of the Composition and Structure of Serum Lipoproteins. Isolation and Characterization of Very High Density Lipoproteins of Human Serum (1966) (55)
- Apolipoprotein C-I Induces Apoptosis in Human Aortic Smooth Muscle Cells via Recruiting Neutral Sphingomyelinase (2004) (55)
- Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels. (1997) (53)
- Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. (2006) (53)
- Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS). (1994) (53)
- Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. (1994) (52)
- Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms (1974) (52)
- Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease). (1981) (52)
- Oxidation Products of Vitamin E and Its Model, 6-Hydroxy-2,2,5,7,8-pentamethyl-chroman. V. Studies of the Products of Alkaline Ferricyanide Oxidation (1963) (51)
- STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: PHYSICAL-CHEMICAL CHARACTERIZATION OF PHOSPHOLIPID-PROTEIN RESIDUES OBTAINED FROM VERY-LOW-DENSITY HUMAN SERUM LIPOPROTEINS. (1964) (51)
- Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2. (1985) (51)
- Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2. (1987) (49)
- Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein B. (1985) (48)
- Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. (1965) (48)
- Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes. (2007) (47)
- Pathophysiology of triglyceride‐rich lipoproteins in atherothrombosis: Clinical aspects (1999) (47)
- Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency. (1982) (47)
- Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance (1992) (47)
- Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia, in Vivo Kinetics (1991) (45)
- Lipid transport in the avian species. Part I. Isolation and characterization of apolipoproteins and major lipoprotein density classes of male turkey serum. (1976) (45)
- The role of apolipoproteins in lipid transport processes (1982) (45)
- The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency. (1985) (43)
- Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay. (1985) (42)
- Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients (2002) (42)
- The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression (1999) (41)
- Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. (1982) (40)
- Progression of renal failure: role of apolipoprotein B-containing lipoproteins. (1997) (40)
- Identification of the protein moiety of an abnormal human plasma low‐density lipoprotein in obstructive jaundice (1969) (39)
- Degradative Effect of Phenol on Endotoxin and Lipopolysaccharide Preparations from Serratia marcescens (1974) (39)
- Identification of lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency. (1973) (36)
- Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia (1999) (35)
- Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma. (1992) (35)
- Dyslipoproteinemia in diabetic renal failure. (1992) (35)
- ISOLATION AND CHARACTERIZATION OF HUMAN CHYLE CHYLOMICRONS AND LIPOPROTEINS * (1968) (34)
- Gastric Drip Feeding in Patients with Glycogen Storage Disease Type I: Its Effects on Growth and Plasma Lipids and Apolipoproteins (1989) (33)
- Studies on the Protein Moiety of Endotoxin from Gram-Negative Bacteria: Characterization of the Protein Moiety Isolated by Phenol Treatment of Endotoxin from S. marcescens 08 and E. coli O 141:K85(B) (1971) (33)
- A Lipoprotein Characterizing Obstructive Jaundice (33)
- EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS. (1963) (32)
- Diagnosis of extrahepatic biliary obstruction in infants by immunochemical detection of LP-X and modified 131 I-Rose Bengal excretion test. (1973) (32)
- Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase. (1982) (32)
- The effect of decreasing renal function on lipoprotein profiles. (2011) (30)
- Isolation and partial characterization of human erythrocyte membrane NADH: (acceptor) oxidoreductase. (1978) (30)
- Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product. (1986) (30)
- The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. (1999) (29)
- Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies. (1986) (29)
- The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus. (1985) (29)
- Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. (1999) (28)
- Rat liver triglyceride lipase. (1966) (27)
- A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. (2005) (26)
- Separation and identification of apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias. (1987) (26)
- A method for the quantitative determination of the abnormal lipoprotein (LP X) of obstructive jaundice. (1972) (26)
- Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency. (2002) (26)
- Composition of Plasma ApoA-I-Containing Lipoprotein Particles in Children and Adults (1991) (25)
- A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus. (2002) (25)
- Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B. (1987) (25)
- Oxidative Stress and Inflammation in Renal Patients and Healthy Subjects (2011) (24)
- Lipids and apolipoprotein profiles in men with aneurysmal and stenosing aorto-iliac atherosclerosis. (1989) (24)
- Comparison of four procedures for separating apolipoprotein A- and apolipoprotein B-containing lipoproteins in plasma. (1987) (24)
- Studies on the protein moiety of endotoxin from gram-negative bacteria. Characterization of the protein moiety isolated by acetic acid hydrolysis of endotoxin from Serratia marcescens 08. (1970) (24)
- Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease. (1997) (23)
- Pathogenesis of hyperlipidemia in the nephrotic syndrome. (1990) (23)
- Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases. (1976) (22)
- Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. (2015) (22)
- Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis. (1980) (22)
- Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. (2012) (22)
- STUDIES ON THE CHARACTERIZATION OF LIPOPOLYSACCHARIDES FROM TWO STRAINS OF SERRATIA MARCESCENS * (1966) (22)
- Analysis of cholesterol ester accumulation in macrophages by the use of digital imaging fluorescence microscopy. (1990) (22)
- Ultracentrifugal characterization of a lipoprotein occurring in obstructive jaundice. (1969) (22)
- Isolation and characterization of the major lipoprotein density classes of normal and diabetic baboon (Papio anubis) plasma. (1978) (21)
- Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat. (2013) (21)
- Peptide composition of human plasma apolipoproteins A, B and C. (1972) (21)
- [An abnormal low density lipoprotein in cholestaris. II. Significance for the differential diagnosis of jaundice]. (1970) (21)
- The differential diagnosis of neonatal hepatitis and biliary atresia. (1974) (21)
- Do High-flux Dialysis Membranes Affect Renal Dyslipidemia? (2001) (20)
- Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles. (1991) (20)
- II. ISOLATION AND PARTIAL CHARACTERIZATION OF THE PROTEIN MOIETIES OF LOW DENSITY LIPOPROTEINS (1970) (20)
- ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth. (2005) (19)
- Glyceraldehyde-3-phosphate dehydrogenase from human erythrocyte membranes. Kinetic mechanism and competitive substrate inhibition by glyceraldehyde 3-phosphate. (1980) (19)
- Use and significance of reference serum as a secondary standard for electroimmunoassay of apolipoprotein A-I. (1984) (19)
- Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D (2019) (19)
- Studies on the protein moiety of endotoxin from gram-negative bacteria. Characterization of the protein moiety isolated by phenol treatment of endotoxin from Serratia marcescens 08 and Escherichia coli 0 141:K85(B). (1971) (18)
- Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. (1973) (18)
- [15] Isolation and characterization of other apolipoproteins (1986) (18)
- Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. II. Isolation of apolipoprotein B-containing lipoproteins from human plasma. (1986) (18)
- apoB-containing lipoprotein particles as risk factors for coronary artery disease. (1991) (18)
- A critical evaluation of the proposal that serum apolipoproteins are the major constituents of the human erythrocyte membrane. (1975) (18)
- Apolipoprotein B–containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis (2012) (18)
- On the Function and Metabolism of Vitamin E III. Vitamin E and Antioxidants in the Nutrition of the Rat (1961) (18)
- Isolation and Composition of Oligosaccharide Cores from Endotoxins of Two Serratia marcescens Strains (1974) (18)
- FAMILIAL HYPERCHOLESTEROLAEMIA AND PRIMARY HYPOTHYROIDISM: COEXISTENCE OF BOTH DISORDERS IN A YOUNG WOMAN WITH SEVERE HYPERCHOLESTEROLAEMIA (1981) (18)
- Modulation of Lipoprotein Lipase Activity by Apolipoproteins (2013) (17)
- Type 2 diabetes and impaired fasting glucose in American Indians aged 5-40 years: the Cherokee diabetes study. (2004) (17)
- Apolipoproteins and lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency. (1974) (17)
- Vitamin E Oxidation with Alkaline Ferricyanide (1963) (17)
- Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease. (1984) (17)
- Lipoprotein particles in hypertriglyceridemic states. (1988) (16)
- Body Mass Index and High-Density Lipoproteins in Cherokee Indian Children and Adolescents (2005) (16)
- Studies of the composition and structure of plasma lipoproteins. C‐ and N‐terminal amino acids of C‐I polypeptide (“R‐Val”) of human plasma apolipoprotein C (1972) (16)
- In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II. (2002) (16)
- Severe hypoalphalipoproteinemia induced by a combination of probucol and clofibrate. (1986) (16)
- Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure. (1984) (16)
- Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase. (1980) (16)
- Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. (1995) (16)
- Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease (2012) (15)
- Studies on the adenine nucleotide translocase from rat liver mitochondria. Isolation, partial characterization and immunochemical properties of carboxyatractylate-binding protein. (1976) (15)
- Apolipoprotein‐Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus (2015) (15)
- Isolation and partial characterization of apolipoprotein D and lipoprotein D from baboon plasma (1980) (15)
- High Density Lipoprotein Metabolism in a Patient with Abetalipoproteinemia (1981) (15)
- Identification and partial characterization of discrete apolipoprotein A-containing lipoprotein particles secreted by human hepatoma cell line HepG2. (1989) (15)
- Abnormalities of lipoprotein composition in renal insufficiency. (1991) (15)
- Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency. (2006) (15)
- [Focus on the classification of plasma lipoproteins]. (1985) (14)
- THE THIN-LAYER CHROMATOGRAPHIC CHARACTERIZATION OF SOME OXIDATION PRODUCTS OF VITAMIN E. (1964) (14)
- Diagnosis and classification of dyslipidemia in renal disease. (1996) (13)
- Effect of chronic heparin administration on serum lipids, lipoproteins, nitrogen and electrolyte balance in normal and heparin-responsive and heparin-unresponsive hyperglyceridemic subjects. (1962) (13)
- Effect of urea on behavior of the protein moiety of human-serum alpha-lipoproteins in solution. (1963) (13)
- Combined Therapy of Niacin, Colestipol, and Fat‐Controlled Diet in Men with Coronary Bypass: Effect on Blood Lipids and Apolipoproteins (1983) (13)
- Quantitative changes of serum lipoprotein‐X after cholestyramine administration in infants with cholestatic biliary tract and liver disease (1978) (13)
- Workshop on apolipoprotein quantification. (1983) (12)
- Metabolism of alpha-tocopherol and the isolation of a nontocopherol-reducing substance from animal tissues. (1961) (12)
- Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. (2013) (12)
- Subcellular fractionation, partial purification and characterization of neutral triacylglycerol lipase from pig liver. (1975) (12)
- Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study. (2005) (11)
- Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins. (2002) (11)
- Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure. (1992) (11)
- Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP). (1992) (11)
- Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins A-I and C-III, variant 1. (1986) (11)
- Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles. (1993) (11)
- Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures (1979) (11)
- Apolipoprotein B-containing lipoprotein particles in progressive renal insufficiency. (1992) (11)
- Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes. (2013) (11)
- On the function and metabolism of vitamin E II. The effects of vitamin E on the level of non-vitamin E reducing compounds present in animal tissues (1960) (10)
- Quantification of the major apolipoproteins in chicken and turkey serum during embryonic development (1980) (10)
- Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis. (2013) (10)
- Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure (1996) (10)
- Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. (1996) (10)
- Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. (1995) (10)
- Apolipoprotein profiles in subjects with and without peripheral artery disease (2013) (10)
- Lipid metabolism in laying hens. The relationship of plasma lipids and liver fatty acid synthetase activity to changes in liver composition. (1978) (10)
- Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee. (2008) (9)
- Identification of Lipoprotein Families in High Density Lipoproteins of Normal Human Plasma (1972) (9)
- Lipid transport in the avian species. Part 2. Isolation and characterization of lipoprotein A and lipoprotein B, two major lipoprotein families of the male turkey serum lipoprotein system. (1976) (8)
- Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2-3 months of age and their parents. (2013) (8)
- Structure-activity relations in the vitamin E series. I. Effects of 5-methyl substitution on 6-hydroxy-2,2,5,7,8-pentamethylchroman. (1967) (8)
- Isolation and characterization of other apolipoproteins. (1986) (8)
- Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humans (2011) (7)
- Relationship between coenzyme Q and α-tocopherol metabolites. (1959) (7)
- Apolipoprotein pattern in patients with chronic renal failure. (1984) (7)
- Separation of ApoA- and ApoB-containing lipoproteins of human plasma by affinity chromatography on concanavalin A. (1991) (7)
- Standardization of Apolipoprotein Immunoassays by an Isotope Dilution Method (1980) (6)
- Familial Chylomicronaemia Due to a Circulating Inhibitor of Lipoprotein Lipase (1983) (6)
- Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. (2013) (6)
- Lipid abnormalities in progressive renal insufficiency. (1997) (6)
- Effect of apo B-containing lipoprotein particles on the progression of atherosclerotic lesions in the Monitored Atherosclerosis Regression Study (MARS) (1994) (6)
- CETP‐mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes (2012) (6)
- Methyltestosterone Effect on Serum Cholesterol Radioactivity in Dogs Given C14-Acetate.∗ (1963) (6)
- Apolipoproteins and lipoprotein families in chicken embryos and egg yolk. (1977) (6)
- Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis (2011) (6)
- Electroimmunoassay and Enzyme Linked Immunosorbent Assay for Quantitative Determination of Plasma Apolipoproteins (1993) (5)
- Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D[S] (2018) (5)
- Use of apolipoprotein parameters and endpoints in drug development and approval processes. (1998) (5)
- EFFECTS OF 12 WEEKS OF EXERCISE TRAINING ON PLASMA LIPIDS AND APOLIPOPROTEINS (APOS) IN MIDDLE-AGED MEN (1982) (5)
- Effects of estrogens on serum lipids and apoproteins of the chicken embryo (1980) (5)
- SERUM-LIPID REDUCING AGENTS AND ANTICOAGULANT REQUIREMENTS (1963) (5)
- and A-Il Polypeptides by Separate Electroimmunoassays (1976) (5)
- Studies on the Protein Moiety of Endotoxin from Gram-Negative Bacteria: Characterization of the Enzymatically Degraded Protein Moiety Isolated by Phenol Treatment of Endotoxin from S. marcescene 08 (1970) (5)
- Determination of serum lipoprotein-X for the early differentiation between neonatal hepatitis and biliary atresia. (1975) (5)
- Immunoaffinity Chromatography of Plasma Lipoprotein Particles (1993) (4)
- [Determination of potentially atherogenic triglyceride-rich lipoprotein particles]. (1990) (4)
- Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity (1993) (4)
- Lipid metabolism in patients with chronic renal failure in the predialytic phase. (1988) (4)
- Influence of Peripheral Artery Disease and Statin Therapy on Apolipoprotein Profiles (2013) (4)
- Apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins in obese girls. (2003) (4)
- On the atherogenicity of triglyceride-rich lipoproteins and a novel marker for the assessment of their atherogenic potentials : Equilibre entre acides gras insaturés : contributions à l'étude de la prévention des maladies cardio-vasculaires (2002) (3)
- Dietary treatment of uraemia and the relation to lipoprotein metabolism. (1992) (3)
- LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (3)
- On the atherogenicity of triglyceride-rich lipoproteins and novel markers for the assessment of their atherogenic potentials (2002) (3)
- [Advances in the analysis of plasma lipoproteins. A new possibility for differential diagnosis of icterus]. (1970) (3)
- Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia (2013) (3)
- Management of dyslipidemia after coronary artery bypass grafting (2000) (3)
- Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease (2011) (3)
- Sex differences in HDL ApoC-III in American Indian youth (2012) (3)
- Relationship of Chemical Structure to Pathophysiological Properties of Endotoxin from 'Serratia marcescens' 08 (1974) (3)
- Levels of cofactors for lipoprotein lipase and lecithin-cholesterol acyltransferase in plasma patients with severe thermal injury. (1988) (3)
- The lipoprotein A-II (LP-A-II) family in normolipidemic subjects and patients with ApoA-I deficiency. (1991) (3)
- The Lipoprotein Family Concept: An Update (1989) (3)
- Determination of Plasma Apolipoprotein Profiles (1983) (3)
- Quantitative Determination ofApolipoproteins C-I andC-Il inHumanPlasma bySeparateElectroimmunoassays (1981) (2)
- Hypercholesterolemia associated with alpha-1 antitrypsin deficiency and hepatitis: lipoprotein and apoprotein determinations, sterol balance and treatment. (1984) (2)
- 750-3 The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Coronary Artery Atherosclerotic Lesions (1995) (2)
- Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. (1973) (2)
- High density lipoprotein metabolism in a patient with abetalipoproteninemia. (1981) (2)
- Abstract: 1467 CONCEPT OF APOLIPOPROTEIN-DEFINED PLASMA LIPOPROTEINS (2009) (1)
- Metabolic Studies in Primary Apolipoprotein (APO CII) Deficiency (1980) (1)
- OR-60: Long-term metabolic effects of a candesartan vs hydrochlorothiazide based antihypertensive treatment: Results of the alpine study (2003) (1)
- Workshop: Plasma Lipoproteins (1974) (1)
- A lipoprotein characterizing obstructive jaundice: isolation and analysis. (1970) (1)
- The role of lipid metabolism in dietary treatment of chronic renal failure. (1990) (1)
- A prominent large high-density lipoprotein at birth enriched in apolipoprotein C-I identifies a new group of infancts of lower birth weight and younger gestational age (2003) (1)
- ISOLATION AND CHARACTERIZATION OF THE MAJOR LIPOPROTEIN DENSITY CLASSES OF NORMAL AND DIABETIC BABOON (1978) (1)
- Treatment of hypertriglyceridaemia. (1969) (1)
- 171 CHARACTERIZATION OF TYPE I AND TYPE II DIABETES BY APOLIPOPROTEIN-DEFINED LIPOPROTEIN SUBCLASSES. (2006) (0)
- Lipoproteins and Atherosclerosis (1987) (0)
- LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans (2018) (0)
- [An abnormal low-density lipoprotein in cholestases. I. Isolation and characterization]. (1970) (0)
- Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis : Cellular aspects. Discussion (1999) (0)
- 178 CHARACTERIZATION OF METABOLIC SYNDROME BY APOLIPOPROTEIN-DEFINED LIPOPROTEIN SUBCLASSES. (2006) (0)
- EFFECT OF PROBUCOL THERAPY ON PLASMA FATTY ACID COMPOSITION DURING POSTPRANDIAL LIPEMIA IN HYPERTRIGLYCERIDEMIA (1997) (0)
- CHARACTERIZATION OF THE PROTEIN MOIETY ISOLATED BY ACETIC ACID HYDROLYSIS (0)
- Changes in plasma lipid and apolipoprotein levels between LDL-apheresis (HELP) treatments in hyperlipidemic patients on lipid-lowering drugs (1994) (0)
- W10-P-012 Relation of FER-HDL and AIP to clinical and laboratory parameters in hats (2005) (0)
- Assessment and Treatment of Cardiovascular Disease in Obese Children (2011) (0)
- QuantitativeDeterminationof ApolipoproteinsC-I andC-Il in HumanPlasma by SeparateElectroimmunoassays (2004) (0)
- Apolipoprotein C-III Bound to Apolipoprotein B-con- taining Lipoproteins in Obese Girls, Piers R. Blackett, 1* (2003) (0)
- Reply to selected summary: A role for apolipoprotein C-III in hypertriglyceridemia? (Gastroenterology 1985;89:1203–1204) (1985) (0)
- Studies on Apolipoprotein D a New Protein Moiety of the Human Plasma Lipoprotein System (1974) (0)
- Subject Index Vol. 25, 1999 (1999) (0)
- Policy Society News (2011) (0)
- Relationship between coenzyme Q and alpha-tocopherol metabolites. (1959) (0)
- Sex differences in HDL ApoC-III in American Indian youth (2012) (0)
- Pistachios beneficially affect multiple lipid and apolipoprotein CVD risk factors (2007) (0)
- Abstract 16195: A Novel Differential Role of Apolipoprotein C-I on the Expression of Large HDL and Triglycerides in Infants at Birth and Follow-Up Compared With Their Parents (2011) (0)
- APOPROTEIN AND NOT CORE LIPID CONTENT ALONE DETERMINE ENGAGEMENT OF IMMUNOCHEMICALLY-DEFINED LIPOPROTEIN SUBCLASSES IN CETP-MEDIATED NEUTRAL LIPID TRANSFER (CET) (2008) (0)
- Necrosamine Series. III.* Preparation of 4-(o-Carboxybenzamido-)5-benzylaminoeicosane and its Hydrolysis to 4 -Amino-5-hydrox yeicosane (1956) (0)
- Choice of Substrate Concentration in the Search for Abnormal Enzyme Activity in Human Tissues (1989) (0)
- Serum lipoprotein-X (LP-X) and biliary atresia (BA). Does an accurate diagnosis obtain? (1978) (0)
- Atherogenic High-Density Lipoprotein in Subjects with Hyperalphalipoproteinemia (2010) (0)
- Contents Vol. 25, 1999 (1999) (0)
- Obstructive Lipoprotein (LP-X) and Liver Disease (1974) (0)
- Body Mass Index and Apolipoproteins C-III, B, and A-I in Young Adult Cherokee (2015) (0)
- Proceedings: Obstructive lipoprotein (LP-X) and liver disease. (1974) (0)
- 4.P.388 Relative importance of apoE in cholesterol efflux (1997) (0)
- 24. The Presence of an Abnormal Low‐Density Lipoprotein in the Serum of Infants with Chronic Obstructive Jaundice (1969) (0)
- Electroimmunoassays of Serum Apolipoproteins in Normolipidemic Subjects and Patients with Primary Hyperlipoproteinemias (1977) (0)
- Metabolic and Clinical Significance of the Lipoprotein Family Concept (1985) (0)
- sedentary and endurance-trained men Circulating plasma VEGF response to exercise in (2015) (0)
- SERUM LP-X IN INFANTILE CHOLESTATIC JAUNDICE /CJ/ (1975) (0)
- Research Abnormal apoC-III distribution and reduced cholesterol efflux capacity of plasma in normolipidemic subjects with premature coronary artery disease (2002) (0)
- Lipid and apolipoprotein predictors of progression from asymptomatic state or impaired glucose tolerance to type 2 diabetes mellitus. (2010) (0)
- Title Pages / Contents (1999) (0)
- [Metabolic changes of cholestatic lipoprotein (LP-X) in the diagnosis of biliary atresia]. (1978) (0)
- Subject Index, Vol. 57, 1991 (1991) (0)
- Relationship of Chemical Structure to Hemodynamic Properties of Endotoxins∗ (1968) (0)
- Meeting Summary Workshop on Apolipoprotein Quantification (2005) (0)
- BIOCHEMICAL AND CLINICAL SIGNIFICANCE OF APOLIPOPROTEINS AND LIPOPROTEIN FAMILIES (1981) (0)
- LIVER PHYSIOLOGY AND DISEASE UTILIZATION OF THE QUANTITATIVE ASSAY OF LIPOPROTEIN X IN THE DIFFERENTIAL DIAGNOSIS OF EXTRAHEPATIC OBSTRUCTIVE JAUNDICE AND INTRAHEPATIC DISEASES (1976) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Petar Alaupovic?
Petar Alaupovic is affiliated with the following schools:
